Sharon H. Hrynkow

Sharon H. Hrynkow, Ph.D. is Chief Scientific Officer and Senior Vice President for Medical Affairs at CTD Holdings, Inc., a Florida-based biotechnology company working to develop cyclodextrin-based drugs for the treatment of diseases with unmet medical need. Dr. Hrynkow leads the company’s clinical programs to test its proprietary cyclodextrin drug product in a rare and fatal disease, Niemann-Pick type C, and in compassionate use in a single late-onset Alzheimer’s patient. She is also Co-Chair of the Company’s Scientific Advisory Board.

Prior to joining CTD, Dr. Hrynkow served in senior leadership roles at the U.S. National Institutes of Health, including as Deputy Director and Acting Director of the John E. Fogarty International Center and as Associate Director of the National Institute on Environmental Health Sciences, and she was Senior Science Advisor at the U.S. Department of State. After 20 years of federal service, Dr. Hrynkow became the inaugural President of the non-profit organization Global Virus Network. She founded and serves as Managing Partner of Global Health Consulting, LLC. A developmental neurobiologist by training, Dr. Hrynkow has devoted her professional career to improving the health of people globally. Her leadership in tackling global issues such as HIV/AIDS, brain disorders, malaria, the threat of pandemic viral disease and most recently rare diseases has brought her national and international recognition. She regularly advises organizations on health and science matters, including in her current role on the US National Academy of Sciences/National Academy of Medicine/National Academy of Engineering Division of Earth and Life Studies Advisory Committee.

Dr. Hrynkow has received numerous honors during her career, including the U.S. President’s Rank Award for Meritorious Senior Executive, the King of Norway’s Order of Merit, and the AAAS “40 by 40” recognition for her work to advance science in service of society. She is an elected member of the Council on Foreign Relations and an elected Fellow of the American Association for the Advancement of Science.